Compare Agilent Technologies Inc (A) vs IQIYI Inc - ADR (IQ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs IQIYI Inc - ADR — how do they compare? Agilent Technologies Inc trades at $128.45 (market cap $37.04B), while IQIYI Inc - ADR trades at $1.05 (market cap $960.59M). The key difference: Agilent Technologies Inc is far larger — about 38.6× IQIYI Inc - ADR's market cap, and Agilent Technologies Inc pays a 0.78% dividend while IQIYI Inc - ADR pays none. Which is the better fit depends on your goals.
| A | IQ | |
|---|---|---|
Market Cap | $37.04B | $960.59M |
Sector | Health | Media |
52-Week High | $157.20 | $2.79 |
52-Week Low | $110.24 | $0.96 |
Enterprise Value | $38.59B | $2.52B |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
iQIYI (IQ) trades at $0.9954, down 1.45% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $206.31 million in 2025 despite $27.29 billion in revenue, with negative profit margins and declining revenue trends. Recent news highlights leadership changes and AI platform expansion, but financial performance remains pressured.
The outlook is mixed: analyst consensus leans bullish with 50% buy ratings, but fundamental weakness and cash flow volatility pose risks. Investment opportunity hinges on AI-driven turnaround execution, while key risks include sustained profitability challenges and competitive pressures in China's streaming market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About IQIYI Inc - ADR
iQIYI Inc is an online entertainment service provider in China. It is primarily engaged in providing a variety of services encompassing internet video, live broadcasting, online games, online literature, animations, e-commerce, and social media platform. The company produces original video content and distributes appealing professionally produced content, partner-generated content, and user-generated content. It also offers a diverse collection of internet video content that appeals to users from broad demographics. The company's revenue is generated from membership services and online advertising services. The company earns most of its revenue from China.
Read more on IQ →
